Vera Bradley shares dropped in premarket after reporting disappointing Q4 FY25 earnings, with a 25% sales decline to $99.96 ...

Consolidated net revenues totaled $372.0 million for the fiscal yearFinancial condition remains strong with no debt and approximately $30 million ...

The lawsuit seeks to block a new rule that requires groups applying for grants from the National Endowment for the Arts to ...

Among phlebotomy-dependent patients with polycythemia vera, the addition of rusfertide to standard-of-care treatment resulted ...

"To optimize our workforce, and in compliance with an Executive Order, NASA is beginning its phased approach to a reduction in force, known as a RIF." ...

Vera’s mission is to advance treatments that target the source of immunological diseases in order to change the standard of care for patients. Vera’s lead product candidate is atacicept ...

Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases ...

Four arts organizations on Thursday sued the National Endowment for the Arts (NEA) over its implementation of President Trump ...

Groups represented by the ACLU are looking to block new National Endowment for the Arts requirements for grant applicants.

If we truly wish to understand and apply Marx's insights today, we must reject the rigid dogmas that later 'Marxists' imposed in his name.' ...